Obermatt
See Similar Stocks →

Hyperfine

NMQ:HYPR · US44916K1060
Health Care Equipment & SuppliesSmall

360

30
Profit price50
Owner Earnings Yield1
Dividend Yield1
Price/Sales24
EV / Gross Profit15
Price/Book1
Return on Capital13
Cash Return on Capital17
Return on Equity26
EBIT Margin1
Gross Profitability6
Accruals78
Owner Earnings Margin4
Sales growth92
Profit growth20
Reinvestment13
Price momentum94
Debt load57
Refinancing45
Debt Payback1
Liquidity1
Analyst ratings100
Opinion Changes3
Price Target Upside45
Market mood100
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Hyperfine doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Employees103
Websitehyperfinemri.com
ISINUS44916K1060
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
NeurologyHealth DiagnosticsNeuroscienceMachine LearningArtificial IntelligenceBiomedical EngineeringHealth CareMedical Device

Description

Hyperfine, Inc. operates as an early-stage health technology company. The company is an innovative health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intell…

Analysis

Story stock

Hyperfine, Inc. trades at an expensive price on a weak set of business metrics, a combination we flag as a story stock.

Valuation data is not available for this company.

Growth is solid; the safety picture is adequate. The company scores 6/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
19
2026

All-time high

59

Mar 2026

All-time low

19

Jun 2026

Average rank

39

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
24
—
—
—
Price/Earnings
64
—
—
—
Price/Book
1
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
12
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Hyperfine with its peers
Ceribell
NSQ:CBLL
37
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Fonar
NAQ:FONR
53
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
IRadimed
NMQ:IRMD
64
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Butterfly Network
NYQ:BFLY
23
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Profound Medical
TOR:PRN
29
CountryCanada
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
ClearPoint Neuro
NAQ:CLPT
18
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →